Cytoplasmic polyadenylated homeobox-like protein 2 (CPHXL2)

Cytoplasmic polyadenylated homeobox-like protein 2 (CPHXL2) is a predicted protein-coding gene with putative DNA-binding transcription factor activity, specifically RNA polymerase II cis-regulatory region sequence-specific DNA binding. It is thought to be involved in the regulation of transcription by RNA polymerase II and predicted to function in the nucleus. There is no evidence it is a validated therapeutic target, nor is there established biological or clinical relevance known as of February 2025[1][7]. CPHXL2 is a poorly characterized, predicted protein. There is no evidence in scientific sources that it is a known or relevant drug target, nor that it is associated with disease roles, interacting drugs, or mechanisms of action[1][7]. All available information comes from gene prediction and sequence databases, with no validation of biological or therapeutic significance. The name most commonly used in scientific and gene databases is "cytoplasmic polyadenylated homeobox like 2" or "cytoplasmic polyadenylated homeobox-like protein 2," abbreviation CPHXL2[1][7]. No experimental or clinical data exists assigning CPHXL2 a specific disease or therapeutic targeting role, and it appears included in databases primarily as a predicted gene by bioinformatic methods.

Other names

Cytoplasmic polyadenylated homeobox like 2CPHXL2cytoplasmic polyadenylated homeobox-like protein 2